Addex Therapeutics (ADXN) Dividends Paid - Common (2019 - 2026)
Addex Therapeutics (ADXN) posted Dividends Paid - Common of $1194.2 billion for Q1 2026, down 62.0% sequentially from $3142.6 billion in Q1 2025, and down 62.0% YoY from $3142.6 billion in Q1 2025.
Addex Therapeutics (ADXN) Dividends Paid - Common (2019 - 2026) Analysis & Trends
Addex Therapeutics has reported Dividends Paid - Common for 8 years, with the latest figure at $1194.2 billion in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 1,194.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,194.19 Bn |
| Mar 31, 2026 | 1,194.19 Bn |
| Mar 31, 2025 | 3,142.65 Bn |
| Mar 31, 2025 | 3,142.65 Bn |
| Sep 30, 2024 | -506.24 Bn |
| Sep 30, 2024 | -506.24 Bn |
| Jun 30, 2024 | 2,388.46 Bn |
| Jun 30, 2024 | 2,388.46 Bn |
| Mar 31, 2024 | 1,864.98 Bn |
| Mar 31, 2024 | 1,864.98 Bn |
| Sep 30, 2023 | -2,734.11 Bn |
| Sep 30, 2023 | -2,734.11 Bn |
| Jun 30, 2023 | 7,973.26 Bn |
| Jun 30, 2023 | 7,973.26 Bn |
| Mar 31, 2023 | 6.05 Mn |
| Mar 31, 2023 | 6.05 Mn |
| Sep 30, 2022 | 1.67 Mn |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | -6.31 Mn |
| Jun 30, 2022 | -6.31 Mn |